Unlock AI-driven, actionable R&D insights for your next breakthrough.

Low Molecular Weight Polyglycolic Acid: Synthesis, Properties, And Advanced Applications In Biodegradable Materials

MAR 25, 202667 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Low molecular weight polyglycolic acid (PGA) represents a specialized class of biodegradable aliphatic polyester with molecular weights typically ranging from 200 to 40,000 g/mol, distinguished from conventional high molecular weight PGA by its unique processing characteristics and targeted applications. This material exhibits enhanced solubility, controlled degradation kinetics, and tailored mechanical properties that make it invaluable in medical devices, pharmaceutical carriers, and emerging sustainable packaging solutions. Understanding the synthesis pathways, structure-property relationships, and application-specific performance parameters of low molecular weight polyglycolic acid is essential for researchers developing next-generation biodegradable materials with optimized functionality.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Structure And Fundamental Characteristics Of Low Molecular Weight Polyglycolic Acid

Low molecular weight polyglycolic acid is characterized by its simplified aliphatic polyester backbone consisting predominantly of glycolic acid repeating units (-OCH₂CO-) with significantly reduced chain length compared to conventional PGA. The molecular weight range for low molecular weight variants typically spans from 200 to 40,000 g/mol 8, with oligomeric forms exhibiting molecular weights as low as 1,000 g/mol 6. This molecular weight reduction fundamentally alters the material's physical state, processing behavior, and degradation profile.

The structural simplicity of low molecular weight polyglycolic acid derives from glycolic acid as the smallest member of the α-hydroxy acid family 3. The polymer chain consists of ester linkages (-COO-) connecting methylene groups, creating a highly regular structure that influences crystallization behavior and hydrolytic susceptibility. Unlike high molecular weight PGA with weight-average molecular weights (Mw) exceeding 30,000 g/mol 6, low molecular weight variants demonstrate enhanced chain mobility and reduced entanglement density.

Key molecular characteristics include:

  • Molecular Weight Distribution: Low molecular weight PGA typically exhibits Mw values between 10,000-40,000 g/mol with polydispersity indices (Mw/Mn) ranging from 1.0 to 10.0 1112, indicating varying degrees of chain length uniformity depending on synthesis method
  • Glycolic Acid Content: High-purity variants contain at least 70 mol% glycolic acid repeating units 15, with homopolymers approaching 100% glycolic acid composition
  • Terminal Group Chemistry: Chain ends feature hydroxyl (-OH) and carboxyl (-COOH) functionalities that can be modified for specific applications 20, enabling conjugation with bioactive molecules or chain extension reactions
  • Crystalline Structure: Despite reduced molecular weight, low molecular weight PGA retains crystalline character with melting points ranging from 197-245°C 15, though crystallinity percentage decreases with molecular weight reduction

The hydrolytic instability inherent to the ester linkage backbone represents a defining characteristic, as physiological conditions trigger random hydrolytic chain scission 2. This degradation mechanism produces glycolic acid monomers that enter metabolic pathways, ultimately converting to water and carbon dioxide through the tricarboxylic acid cycle 2. The degradation rate inversely correlates with molecular weight, making low molecular weight variants particularly suitable for applications requiring accelerated biodegradation timelines of 4-6 months 2.

Synthesis Methodologies For Low Molecular Weight Polyglycolic Acid Production

The production of low molecular weight polyglycolic acid employs fundamentally different synthetic strategies compared to high molecular weight PGA manufacturing, with process selection critically influencing molecular weight distribution, purity, and end-group functionality.

Polycondensation Approaches

Direct polycondensation of glycolic acid or its derivatives represents the most straightforward route to low molecular weight PGA, though historically limited by inherent molecular weight ceiling 37. The process involves stepwise esterification reactions between carboxyl and hydroxyl groups with concurrent water elimination:

n HOCH₂COOH → HO[-CH₂CO-O-]ₙH + (n-1) H₂O

Process Parameters and Limitations:

  • Temperature Range: 100-160°C under normal or reduced pressure for oligomer formation 6, with higher temperatures (180-230°C) required for solid-state post-polymerization 6
  • Catalyst Systems: Acid catalysts (p-toluenesulfonic acid, sulfuric acid) or metal-based catalysts (tin compounds, titanium alkoxides) accelerate esterification, though residual catalyst can promote degradation
  • Molecular Weight Control: Conventional polycondensation typically yields Mw < 10,000 g/mol 37 due to equilibrium limitations and increasing melt viscosity restricting water removal
  • Purity Challenges: Side reactions including decarboxylation, ether formation, and cyclic oligomer generation reduce yield and introduce structural defects

A modified three-step polycondensation process addresses some limitations 6:

  1. Oligomerization: Dehydration of glycolic acid aqueous solution at 100-160°C to produce oligomers with Mw ≥ 1,000 g/mol
  2. Purification: Immersion of oligomers in water or alkaline solution at 20-90°C to extract impurities and low molecular weight species
  3. Solid-State Polymerization: Drying followed by heating at 180-230°C in inert gas flow to achieve Mw ≥ 30,000 g/mol while maintaining low coloration

Direct polycondensation of methyl glycolate offers advantages including reduced side reactions and improved color stability 1112. This approach enables production of PGA with Mw ranging from 10,000-1,000,000 g/mol and Mw/Mn of 1.0-10.0 1112, with melt flow rates (MFR) of 0.1-1000 g/10 min at 230°C/2.16 kg 1112.

Controlled Degradation Of High Molecular Weight PGA

An alternative strategy involves intentional depolymerization of conventional high molecular weight PGA through controlled hydrolytic or thermal degradation. This approach provides access to specific molecular weight ranges while maintaining high glycolic acid content.

Hydrolytic Degradation:

  • Exposure of high Mw PGA to aqueous environments at elevated temperatures (60-90°C) induces random chain scission
  • pH control (acidic or basic conditions) modulates degradation rate
  • Molecular weight reduction follows pseudo-first-order kinetics, enabling time-based targeting of desired Mw ranges
  • Purification steps remove degradation byproducts and low molecular weight oligomers

Thermal Degradation:

  • Prolonged heat treatment under vacuum at temperatures approaching but below melting point 13
  • Controlled thermal history enables molecular weight adjustment while minimizing discoloration
  • Process requires careful temperature and time optimization to avoid excessive degradation or crosslinking

Ring-Opening Polymerization With Chain Transfer

While ring-opening polymerization (ROP) of glycolide typically produces high molecular weight PGA, incorporation of chain transfer agents enables molecular weight control 3. Monofunctional alcohols or carboxylic acids act as chain terminators, limiting polymer chain growth:

  • Chain Transfer Agent Selection: Methanol, ethanol, or lauryl alcohol for hydroxyl-terminated chains; acetic acid or benzoic acid for carboxyl-terminated chains
  • Stoichiometric Control: Chain transfer agent concentration inversely correlates with final molecular weight
  • Catalyst Systems: Tin(II) 2-ethylhexanoate (stannous octoate) remains the preferred catalyst for biomedical applications due to FDA approval
  • Reaction Conditions: 180-220°C under inert atmosphere with precise moisture exclusion

This approach offers superior control over molecular weight distribution (narrow Mw/Mn) and end-group functionality compared to polycondensation, though glycolide monomer synthesis remains technically challenging with poor collected yields and high side product formation 3.

Reactive Extrusion For Molecular Weight Enhancement

Recent innovations employ reactive extrusion to increase molecular weight of low Mw PGA oligomers produced by polycondensation 7. This continuous process combines:

  • Chain Extension: Addition of difunctional chain extenders (diisocyanates, dianhydrides, or bisoxazolines) that react with terminal hydroxyl or carboxyl groups
  • Devolatilization: Efficient removal of condensation byproducts under vacuum
  • Residence Time Control: Typical residence times of 2-10 minutes enable significant Mw increase (Mw,final/Mw,initial ratios > 2) 7
  • Temperature Management: 200-240°C processing temperatures balance reaction kinetics with thermal stability

This economically feasible approach circumvents challenging glycolide synthesis while achieving high molecular weight materials suitable for demanding applications 7.

Physical And Chemical Properties Of Low Molecular Weight Polyglycolic Acid

The reduced molecular weight of low Mw PGA fundamentally alters its physical state, thermal behavior, mechanical properties, and chemical reactivity compared to conventional high molecular weight variants.

Thermal Properties And Phase Behavior

Melting Characteristics:

  • Melting point (Tm) ranges from 197-245°C 15, with values decreasing as molecular weight decreases below 20,000 g/mol due to reduced crystalline perfection
  • Melt crystallization temperature (Tc2) spans 130-195°C 15, indicating substantial supercooling and crystallization kinetics sensitivity to molecular weight
  • Glass transition temperature (Tg) typically falls between 35-45°C for PGA homopolymers, with minimal molecular weight dependence above oligomeric range

Thermal Stability:

  • Onset of thermal degradation (3% weight loss) occurs at temperatures ≥ 270°C under nitrogen atmosphere at 2°C/min heating rate 17, providing adequate processing window
  • Thermogravimetric analysis (TGA) reveals multi-stage degradation: initial weight loss from residual monomers/oligomers (150-200°C), followed by main chain scission (250-350°C)
  • Low molecular weight variants exhibit slightly reduced thermal stability due to higher concentration of reactive chain ends

Melt Rheology:

  • Melt viscosity at processing temperatures (230-250°C) decreases dramatically with molecular weight reduction, facilitating processing but potentially limiting certain applications 1
  • Melt flow rate (MFR) at 230°C/2.16 kg ranges from 0.1-1000 g/10 min depending on molecular weight 1112, with low Mw variants exhibiting MFR > 100 g/10 min
  • Melt strength (resistance to extensional flow) ranges from 50-300 mN at 230°C 17, critical for blow molding and film extrusion applications

Mechanical Properties

Low molecular weight PGA exhibits significantly different mechanical behavior compared to high Mw variants due to reduced chain entanglement density and crystallinity:

Tensile Properties:

  • Tensile modulus can exceed 5,800 MPa when formulated with appropriate fillers 1112, though neat low Mw PGA typically exhibits modulus of 2,000-4,000 MPa
  • Tensile strength ranges from 30-60 MPa for molecular weights of 10,000-40,000 g/mol, substantially lower than high Mw PGA (70-100 MPa)
  • Elongation at break increases with molecular weight reduction, ranging from 5-20% for low Mw variants versus 2-10% for high Mw PGA

Flexural Properties:

  • Flexural modulus parallels tensile modulus trends, with values of 3,000-6,000 MPa depending on molecular weight and crystallinity
  • Flexural strength ranges from 50-90 MPa, adequate for semi-structural applications

Impact Resistance:

  • Notched Izod impact strength decreases with molecular weight reduction, typically 2-5 kJ/m² for low Mw PGA versus 5-15 kJ/m² for high Mw variants
  • Brittleness increases as molecular weight decreases below 15,000 g/mol, limiting applications requiring toughness

Solubility And Solution Properties

Enhanced solubility represents a key advantage of low molecular weight PGA for solution-based processing and pharmaceutical applications:

Solvent Selection:

  • Aprotic polar solvents including N,N-dimethylformamide (DMF), N,N-dimethylacetamide (DMAc), dimethyl sulfoxide (DMSO), and 1,4-dioxane readily dissolve low Mw PGA at concentrations up to 50 wt% 815
  • Halogenated solvents (chloroform, dichloromethane) provide good solubility at room temperature for molecular weights < 20,000 g/mol
  • Hexafluoroisopropanol (HFIP) serves as a universal solvent for PGA across all molecular weight ranges, useful for characterization
  • Tetrahydrofuran (THF) exhibits limited solubility for PGA, requiring elevated temperatures (50-70°C) 8

Solution Processing:

  • Solution viscosity at fixed concentration decreases with molecular weight, enabling higher solid content formulations for coating and fiber spinning applications
  • Precipitation from solution by addition of non-solvents (water, alcohols) produces particles with controlled size distribution 15
  • Solution stability depends on residual moisture and temperature, with hydrolytic degradation accelerated in solution phase

Barrier Properties

Despite reduced molecular weight, low Mw PGA retains excellent gas barrier characteristics inherent to the polyglycolic acid structure:

  • Oxygen transmission rate (OTR) remains exceptionally low (< 0.1 cc·mm/m²·day·atm at 23°C, 0% RH) for molecular weights > 15,000 g/mol 1
  • Carbon dioxide permeability similarly exhibits values among the lowest of thermoplastic polymers
  • Water vapor transmission rate (WVTR) increases compared to high Mw PGA due to reduced crystallinity and increased free volume

Biodegradation Kinetics

The degradation rate of low molecular weight PGA in biological and environmental media represents a critical performance parameter:

Hydrolytic Degradation Mechanism:

  • Random ester bond scission via water attack, catalyzed by acids or bases 2
  • Degradation rate increases with decreasing molecular weight due to higher chain end concentration and enhanced water penetration
  • Autocatalytic acceleration occurs as carboxylic acid end groups accumulate, particularly in bulk samples

Degradation Timeline:

  • Complete resorption in physiological conditions occurs within 4-6 months for low Mw PGA 2, compared to 6-12 months for high Mw variants
  • In vitro degradation studies in phosphate buffered saline (PBS, pH 7.4, 37°C) show 50% molecular weight loss within 2-4 weeks for initial Mw of 10,000-20,000 g/mol
  • Environmental degradation in soil or compost proceeds more slowly (6-18 months) depending on microbial activity, moisture, and temperature

Degradation Products:

  • Primary degradation product is glycolic acid monomer, a non-toxic metabolite 2
  • Glycolic acid enters the tricarboxylic acid (TCA) cycle, ultimately converting to CO₂ and H₂O 2
  • No toxic or persistent degradation products accumulate, supporting environmental safety claims

Applications Of Low Molecular Weight Polyglycolic Acid In Medical And Pharmaceutical Systems

The unique combination of biodegradability, biocompatibility, controlled degradation kinetics, and enhanced processability positions low molecular weight PGA as a valuable material for diverse medical and pharmaceutical applications.

Surgical Sutures And Wound Closure Devices

Low molecular weight PGA serves as a critical component in absorbable surgical sutures, where controlled degradation timing matches tissue healing rates 27:

Material Requirements:

  • Molecular weight range of 15,000-40,000 g/mol provides optimal balance between initial tensile strength (sufficient for wound closure) and degradation timeline (complete absorption within 60-90 days)
  • Fiber spinning from solution or melt enables production of monofilament or braided suture configurations
  • Surface treatments or coatings with low Mw PGA oligomers (Mw < 5,000 g/mol) reduce tissue drag and improve handling characteristics

Performance Characteristics:

  • Initial tensile strength of 400-600 MPa for drawn fibers decreases to 50% of original value within 14-21 days post-implantation
  • Complete tensile strength loss occurs by 28-35 days, with mass loss and absorption continuing through 60-90 days
  • Minimal inflammatory response due to biocompatible degradation products and absence of toxic additives

Clinical Applications:

  • Subcutaneous and dermal layer closure in general surgery
  • Ga
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
KUREHA CORPORATIONBiodegradable packaging materials including films, sheets, and bottles requiring exceptional oxygen barrier performance for food preservation and pharmaceutical applications.PGA Packaging FilmsLow melt viscosity polyglycolic acid with molecular weight control enabling melt flow rate of 0.1-1000 g/10 min at 230°C, providing excellent gas barrier properties (OTR < 0.1 cc·mm/m²·day·atm) while maintaining processability for single-layer and multi-layer structures.
Smith & Nephew PLCTissue engineering scaffolds and wound closure devices for subcutaneous and dermal layer applications in general surgery requiring biocompatible degradation matching tissue healing rates.Absorbable Surgical ScaffoldsPLGA copolymer scaffolds with controlled LA:GA ratios (85:15 to 99:1) providing tailored degradation kinetics of 4-6 months, complete resorption with non-toxic glycolic acid metabolites entering tricarboxylic acid cycle for conversion to CO₂ and H₂O.
Teknologian tutkimuskeskus VTT OyCost-effective production of high molecular weight biodegradable polyesters for medical devices, sustainable packaging, and barrier materials without complex lactonization steps.Reactive Extrusion PGAMolecular weight enhancement through reactive extrusion achieving Mw increase ratios >2 with residence times of 2-10 minutes at 200-240°C, circumventing challenging glycolide synthesis while producing high molecular weight aliphatic polyesters economically.
Pujing Chemical Industry Co. Ltd.High-temperature resistant applications including downhole tools, pharmaceutical carriers, and blow-molded containers requiring superior mechanical properties and thermal stability up to 270°C.High-Performance PGA CompositesDirect polycondensation of methyl glycolate producing PGA with Mw 10,000-1,000,000 and Mw/Mn 1.0-10.0, achieving tensile modulus >5,800 MPa with filler incorporation and melt strength 50-300 mN at 230°C for blow molding applications.
MITSUI CHEMICALS INCMedical polymer materials for surgical sutures and artificial skins requiring high purity, low coloration, and controlled molecular weight distribution for biomedical applications.Low-Color PGA OligomersThree-step polycondensation process producing stable low-colored PGA with Mw ≥30,000 through oligomerization at 100-160°C, aqueous purification at 20-90°C, and solid-state polymerization at 180-230°C, minimizing discoloration while achieving sufficient molecular weight.
Reference
  • Low-melt-viscosity polyglycolic acid, process for producing the same, and use of the low-melt-viscosity polyglycolic acid
    PatentInactiveEP2189486A1
    View detail
  • scaffold
    PatentWO2007132186A2
    View detail
  • Glycolic acid polymers and method of producing the same
    PatentWO2014181040A1
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png